Canakinumab first or second choice in systemic juvenile idiopathic arthritis-experience from clinical practice

Category Primary study
JournalArthritis and Rheumatology
Year 2017
This article has no abstract
Epistemonikos ID: 28f71e2c77dd4133ea37af79133930d47c300dfe
First added on: Feb 08, 2025